Novavax posts higher-than-expected revenue, says prepared to further cut costs

COVID-19 vaccine maker Novavax https://www.reuters.com/markets/companies/NVAX.O” target=”_blank” rel=”noopener”>(NVAX.O) on Thursday beat market estimates for quarterly revenue, boosted by U.S. government grants to help cover the expense of clinical trials, and…
Read More

About The Author

Jonathan Jeriah

See author's posts